28 Apr 2026

Quantum is still early, that may be the point…

Over $30 billion has already been committed to quantum technologies globally, and while the field remains at an early stage, it has clearly moved beyond pure theory into a phase of serious commercial experimentation that is starting to attract sustained enterprise attention.

Large organisations are not waiting for full maturity before engaging. They are already running pilots and forming partnerships to understand where quantum could create an edge. Firms such as Goldman Sachs are exploring how quantum approaches might enhance portfolio optimisation and risk modelling, while BMW and Volkswagen are testing its potential in battery chemistry and advanced materials. In life sciences, Amgen is investigating whether quantum machine learning techniques can accelerate parts of the drug discovery process, particularly where classical methods begin to hit limits

Read more here: https://bit.ly/4vX8HOI